Related references
Note: Only part of the references are listed.Effects of Physical Exercise on Depressive Symptoms and Biomarkers in Depression
Trevor Archer et al.
CNS & Neurological Disorders-Drug Targets (2015)
Towards a “Metabolic” Subtype of Major Depressive Disorder: Shared Pathophysiological Mechanisms May Contribute to Cognitive Dysfunction
Celina Liu et al.
CNS & Neurological Disorders-Drug Targets (2015)
Involvement of nitric oxide in granisetron improving effect on scopolamine-induced memory impairment in mice
Mehrak Javadi-Paydar et al.
BRAIN RESEARCH (2012)
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models
Young-Jung Lee et al.
JOURNAL OF NEUROINFLAMMATION (2012)
The effects of age and lipopolysaccharide (LPS)-mediated peripheral inflammation on numbers of central catecholaminergic neurons
P. R. Mouton et al.
NEUROBIOLOGY OF AGING (2012)
Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: Multiplex quantification with path analysis
Michelle A. Erickson et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Suppression of nitric oxide synthesis by L-NAME reverses the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice
Nika Allami et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Systemic administration of lipopolysaccharide induces molecular and morphological alterations in the hippocampus
Grzegorz A. Czapski et al.
BRAIN RESEARCH (2010)
Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model
Paula Borel et al.
INTERNATIONAL IMMUNOLOGY (2008)
Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation
Jae Woong Lee et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Mechanism of action of glatiramer acetate in treatment of multiple sclerosis
Martin S. Weber et al.
NEUROTHERAPEUTICS (2007)
Glatiramer acetate: Mechanisms of action in multiple sclerosis
Wiebke Schrempf et al.
AUTOIMMUNITY REVIEWS (2007)
Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate
D Azoulay et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines:: Implications for multiple sclerosis therapy
T Ziemssen et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease
MD Boska et al.
JOURNAL OF NEUROSCIENCE (2005)
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
EJ Benner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ
R Aharoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis
DN Angelov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Glatiramer acetate-specific T-helper 1-and 2-type cell lines produce BDNF:: implications for multiple sclerosis therapy
T Ziemssen et al.
BRAIN (2002)
Expression and regulation of interleukin-1 receptors in the brain.: Role in cytokines-induced sickness behavior
P Parnet et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Attenuation of LPS-induced changes in synaptic activity in rat hippocampus by Vasogen's Immune Modulation Therapy
Y Nolan et al.
NEUROIMMUNOMODULATION (2002)
Neuroscience - The molecular biology of memory storage: A dialogue between genes and synapses
ER Kandel
SCIENCE (2001)
Mechanisms of action of glatiramer acetate in multiple sclerosis
O Neuhaus et al.
NEUROLOGY (2001)
Risk-benefit assessment of glatiramer acetate in multiple sclerosis
T Ziemssen et al.
DRUG SAFETY (2001)
Mechanisms of immunomodulation by glatiramer acetate
B Gran et al.
NEUROLOGY (2000)
Share Paper
